Van Eck Associates Corp Artivion, Inc. Transaction History
Van Eck Associates Corp
- $88.3 Billion
- Q2 2025
A detailed history of Van Eck Associates Corp transactions in Artivion, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 2,670 shares of AORT stock, worth $112,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,670Holding current value
$112,940% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
200Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$281 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$125 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$118 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$118 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$98.1 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.71B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...